AIZ vs COYA · P/E 15, rev $3.45B vs rev $7.9M
Assurant Inc (AIZ) versus Coya Therapeutics, Inc. Common Stock (COYA) — a side-by-side from cached financials, not a winner call.
Assurant Inc (AIZ) is a insurance - property & casualty company listed on US.
Coya Therapeutics, Inc. Common Stock (COYA) is a biotechnology company listed on NASDAQ.
Latest reported AIZ revenue for 2026-06-30 was $3.45B. Net income was $298.6M. Revenue was up 1.0% from 2026-03-31 to 2026-06-30. AIZ currently screens at market cap $9.98B and trailing P/E 15.4.
Latest reported COYA revenue for 2025-12-31 was $7.9M. Net income was -$21.2M. Revenue was up 123.6% from 2024-12-31 to 2025-12-31. COYA currently screens at market cap $118.0M.
AIZ currently screens at market cap $9.98B and trailing P/E 15.4. COYA currently screens at market cap $118.0M.
Not investment advice. Open the AIZ and COYA stock pages for the full models.
Not investment advice.